As we reflect on our journey, from our humble beginnings with our inaugural scientific meeting in Daegu, Korea in April 2009, to now celebrating our 15th year, it fills us with immense pride to witness the evolution of the Pulse of Asia (POA). What started as a focused exploration into arterial stiffness and pulsatile hemodynamics has blossomed into a comprehensive platform covering the vast landscape of vascular science.

In the spirit of continuous evolution, we are delighted to announce the expansion of the POA to include five pivotal areas: Arterial Stiffness and Vascular Aging, Vascular Health in the Clinic, Clinical Trials and Translational Vascular Research, Genetics and Precision Medicine, and Future Medicine with a focus on Artificial Intelligence (AI) and Telemedicine. This strategic expansion reflects our commitment to staying at the forefront of emerging trends and technologies, ensuring that our society remains a beacon of innovation in vascular science.

Furthermore, we are thrilled to share that our official journal, PULSE (Karger Publisher, Basel, Switzerland), has achieved a notable journal impact factor of 2.2 in 2023. This milestone speaks volumes about the caliber of research and scholarship within our community, and it emboldens us to strive for even greater heights.

As we emerge from the shadow of the COVID-19 pandemic, let us seize this moment to propel the Pulse of Asia to new heights. With your enthusiastic participation and unwavering support, we are confident that we will once again position the POA at the forefront of vascular science, guiding research and practice towards a brighter future.

We eagerly anticipate the opportunity to collaborate, innovate, and inspire as we embark on this exciting journey together.

Warmest regards,

Jeong Bae Park, Executive Director
On behalf of the POA